Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 4791-4798, September 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldaz, C. M.
Right arrow Articles by Zappler, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldaz, C. M.
Right arrow Articles by Zappler, K.

Nonrandom Abnormalities Involving Chromosome 1 and Harvey-ras-1 Alleles in Rat Mammary Tumor Progression1

C. Marcelo Aldaz2, Aaron Chen, Lauren S. Gollahon, Jose Russo and Konrad Zappler

Department of Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Smithville, Texas 78957 [C. M. A., A. C., L. S. G., K. Z.], and Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [J. R.]

Little is known about the role of chromosomal abnormalities in the widely used models of rat mammary carcinogenesis. In this study, we cytogenetically analyzed nitrosomethylurea-induced rat mammary adenocarcinomas at different time points of development. As tools to study more advanced stages of malignant progression, we also analyzed the cytogenetic progression of tumors transplanted into younger syngeneic hosts, and of tumors that did not regress or that developed after host ovariectomy. Our results indicate that rat mammary adenocarcinomas appear to start development as diploid lesions with cytogenetically "normal" karyotypes. However, upon progression, tumors showed coexistence of normal diploid clones with abnormal clones bearing specific abnormalities affecting mainly chromosomes 1 and 15. Almost every ovary-independent tumor presented stem lines with specific nonrandom chromosomal abnormalities. Numerical chromosomal abnormalities such as specific trisomies started to develop mainly after subsequent in vivo transplantations. The abnormalities affecting chromosome 1 observed in many tumors were: (a) interstitial deletions and breakpoints for translocation in region 1q22; and (b) partial or complete overrepresentation of chromosome 1 in the form of direct duplication of region 1q22q43 or as trisomy 1. Interestingly, Harvey-ras-1 gene maps to rat chromosome 1, and by Southern analysis we observed that 4 of 8 primary tumors and 6 of 9 ovary-independent tumors showed considerable loss of Harvey-ras-1 signal indicating probable allele loss. However, analyses of some tumor transplants in more advanced stages of progression showed, paradoxically, an increased copy number of the Harvey-ras-1 oncogene coinciding with the presence of the direct duplication observed in chromosome 1 or with trisomy 1 as possible mechanisms for gene amplification.

Interestingly, rat chromosome 1 is the homologue to human chromosome 11, and in numerous cases of human breast cancer loss of heterozygosity of several genes in chromosome 11p15.5 has been reported. Some of the rat chromosome 1 abnormalities observed may be equivalent to those affecting 11p15 in human tumors.

We also observed 8 tumors with abnormalities affecting chromosome 15. At least 3 genes of interest in breast cancer have been previously mapped to that rat chromosome.

The similarities observed with human breast cancer may point to common mechanisms of tumor progression in both species.

1 This study was supported by NIH Grant CA 48922 (C. M. A.).

2 To whom requests for reprints should be addressed, at Department of Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, P.O. Box 389, Smithville, TX 78957.

Received 3/30/92. Accepted 6/16/92.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. M. Chan, X. Lu, F. M. Merchant, J.D. Iglehart, and P. L. Miron
Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer
Carcinogenesis, August 1, 2005; 26(8): 1343 - 1353.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. J. Seraj, R. S. Samant, M. F. Verderame, and D. R. Welch
Functional Evidence for a Novel Human Breast Carcinoma Metastasis Suppressor, BRMS1, Encoded at Chromosome 11q13
Cancer Res., June 1, 2000; 60(11): 2764 - 2769.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. C. Popescu and J. W. Greiner
Recurrent alterations of the short arm of chromosome 3 define a tumor suppressor region in rat mammary tumor cells
Carcinogenesis, October 1, 1999; 20(10): 2033 - 2036.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L A Donehower, L A Godley, C M Aldaz, R Pyle, Y P Shi, D Pinkel, J Gray, A Bradley, D Medina, and H E Varmus
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.
Genes & Dev., April 1, 1995; 9(7): 882 - 895.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.